ID
36768
Beschreibung
Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria This study (Malaria-039 / NCT00323622 / GlaxoSmithKline Study ID 104297) is a two-year follow-up to Malaria-026 and consists of three clinic visits: Visit 1 / Informed Consent Visit at Visit 7 of Malaria-026 (i.e. 21 months post vaccine dose 1 in Malaria-026). Visit 2 / Interim Analysis 12 months +/- 1 month after Visit 1. Visit 3 / Final Analysis 24 months +/- 1 month after Visit 1. See https://clinicaltrials.gov/ct2/show/NCT00323622 This form is to be completed at Visit 2.
Link
https://clinicaltrials.gov/ct2/show/NCT00323622
Stichworte
Versionen (2)
- 11.12.18 11.12.18 -
- 06.06.19 06.06.19 -
Rechteinhaber
GSK group of companies
Hochgeladen am
6. Juni 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Immunogenicity of malaria vaccine candidate - NCT00323622 / Malaria-039
Visit 2: Study Continuation Check
- StudyEvent: ODM
Beschreibung
Check for Study Continuation
Alias
- UMLS CUI-1
- C2348568
- UMLS CUI-2
- C0805733
Beschreibung
If Yes, please complete the next pages. If No, Please tick the ONE most appropriate reason and skip the following pages of this visit, and please tick who took the decision.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0805733
- UMLS CUI [1,3]
- C0008976
Beschreibung
Reason for discontinuation
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C0008976
Beschreibung
complete the Serious Adverse Event form
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0600091
- UMLS CUI [1,2]
- C1519255
Beschreibung
e.g.: consent withdrawal, Protocol violation, non-serious adverse event …
Datentyp
text
Alias
- UMLS CUI [1,1]
- C3840932
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [1,4]
- C1521902
Beschreibung
Discontinuation decision
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C0008976
Ähnliche Modelle
Visit 2: Study Continuation Check
- StudyEvent: ODM
C0805733 (UMLS CUI-2)
C0805733 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0457454 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
C0457454 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])